Filtering
- 5-Fluoruracil
- 5-Fu, oxaliplatin , leucovorin
- 5-HT3 antagonist
- 5-Hydroxytryptophan
- 5-Hydroxytryptophan 100 MG
- 5-aminolevulinic acid
- 5-aminosalicylic acid
- 5-azacitidine
- 5-azacytidine
- 5-day Temozolomide
- 5-fluoro-uracil
- 5-fluorouracil
- 5-fluorouracil (5-FU)
- 5-fluorouracil-based chemotherapy
- 5-fluoruracil
- 5-fu
- 5-mg Desloratadine
- 50 mcg salmeterol HFA MDI
- 50 mg Proellex
- 50 mg etanercept
- 50 mg of KX2-391 Ointment 1%
- 50 mg/mL Virazole
- 500 mg CK-2017357
- 500 mg metformin
- 552-02
- 5ARI
- 5ARI + AB
- 5FU
- 5Fluorouracil
- 5HTP
- 5fluorouracil
- 5mg Serlopitant Tablets
- 6 Mercaptopurine
- 6 cycles chemotherapy
- 6 months DAPT
- 6 months treatment with a single antiplatelet agent
- 6% hydroxyethyl starch 130/0.4
- 6,8-Bis(benzylthio)octanoic Acid
- 6,8-bis(benzylthio)octanoic acid
- 6-Mercaptopurine
- 6-Thioguanine
- 6-[18F]Fluorodopamine
- 6-mercaptopurine
- 6-thioguanine
- 60 mg dexlansoprazole capsules manufactured at TOB
- 60 mg dexlansoprazole capsules manufactured at TPC
- 60% Oxygen
- 600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL
- 600 mg Ceftaroline fosamil
- 601 1.25mg
- 609A
- 64Cu-ATSM
- 64Cu-DOTA-ECL1i
- 64Cu-FBP8
- 64Cu-SAR-BBN
- 64Cu-SAR-bisPSMA
- 64Cu-SARTATE
- 68-Ga PSMA11
- 68Ga PSMA-11 injection
- 68Ga-BBN-IRDye800CW
- 68Ga-BNOTA-PRGD2
- 68Ga-DOTA-FAPI
- 68Ga-DOTATATE
- 68Ga-DOTATATE PET/CT
- 68Ga-DOTATOC PET/CT
- 68Ga-Dotatate
- 68Ga-FAP-2286
- 68Ga-FAP-CHX
- 68Ga-FAP-RGD
- 68Ga-FAPI
- 68Ga-FAPI-04
- 68Ga-FAPi-46
- 68Ga-HBED-CC-PSMA
- 68Ga-HTK03149
- 68Ga-NEB
- 68Ga-NODAGA-E[c(RGDyK)]2
- 68Ga-NOTA-AE105
- 68Ga-NOTA-BBN-RGD
- 68Ga-NOTA-RM26
- 68Ga-NOTA-exendin-4
- 68Ga-NY104
- 68Ga-P16-093
- 68Ga-PSMA
- 68Ga-PSMA-11
- 68Ga-PSMA-617 PET/CT
- 68Ga-PSMA-HBED-CC
- 68Ga-Pentixafor
- 68Ga-RGD
- 68Ga-RM2
- 68Ga-RM2 PET/CT
- 68GaNOTA-Anti-HER2 VHH1
- 68GaNOTA-Anti-MMR-VHH2
- 6MW3211
- 6R-BH4
- 7% Hypertonic Saline (HS)
- 7-hydroxystaurosporine
- 7-hydroxystaurosporine (UCN-01)
- 70% ethanol
- 70% glycolic acid
- 70% isopropyl alcohol
- 700 µg Dexamethasone
- 75 mg linzagolix tablet
- 8% NVN1000 Topical Gel
- 8-Chloroadenosine
- 8.0% Arginine Dentifrice
- 80 mg ixekizumab
- 81mg aspirin
- 850 mg metformin
- 851B
- 852A
- 88% sucrose po solution
- ⁸⁹Zr-Df-IAB22M2C
- 89Zr-Girentuximab
- 89Zr-J591
- 89Zr-Pembrolizumab
- 89Zr-TLX250 PET/CT
- 89Zr-bevacizumab
- 8IU intranasal oxytocin
- 9-ING-41
- 9-NC in aerosol reservoir
- 90 mcg Reference Product
- 90 mcg Test Product
- 90Y Ibritumomab tiuxetan
- 90Y Zevalin
- 90Y-epratuzumab tetraxetan
- 90Y-hPAM4
- 90Y-ibritumomab tiuxetan (Zevalin)
- 91-day Levonorgestrel Oral Contraceptive
- 98% dehydrated alcohol
- 99Tc-MDP
- 99mTc-3PRGD2
- 99mTc-DARPinG3
- 99mTc-MIP-1404
- 99mTc-PYP
- 9MW0813
- 9MW2821
- A
- A (canagliflozin and metformin IR individual tablets) / B (canagliflozin/metformin IR FDC tablets)
- A PD-1 inhibitor
- A-002
- A-007
- A-101
- A-101 Solution
- A-101 Topical Solution
- A-101 Vehicle
- A-101 Vehicle Solution
- A-623
- A006 DPI
- A166
- A3309
- A4250
- A4250 (odevixibat)
- AAB-003 (PF-05236812)
- AAE581
- AAT( Alpha 1 Antitrypsin)
- AAV-hTERT
- AAV2-hAADC
- AAV8-hCocH
- AB-101
- AB-106
- AB-16B5
- AB-729
- AB-836
- AB1010
- AB103
- AB122
- AB521
- AB680
- AB928
- ABBV-066
- ABBV-154
- ABBV-181
- ABBV-368
- ABBV-382
- ABBV-383
- ABBV-399
- ABBV-552
- ABBV-576
- ABBV-744
- ABBV-838
- ABBV-8E12
- ABBV-927
- ABBV-951
- ABBV-CLS-7262
- ABC/3TC
- ABC/DTG/3TC
- ABC/DTG/3TC Placebo
- ABC008
- ABC294640
- ABD-3001
- ABI-007
- ABI-007 (Abraxane)
- ABI-009
- ABI-011
- ABI-1968
- ABI-H0731
- ABI-H2158
- ABL001
- ABLC
- ABM-1310